GB1199632A - Alkanolamine Derivatives - Google Patents

Alkanolamine Derivatives

Info

Publication number
GB1199632A
GB1199632A GB40961/67A GB4096167A GB1199632A GB 1199632 A GB1199632 A GB 1199632A GB 40961/67 A GB40961/67 A GB 40961/67A GB 4096167 A GB4096167 A GB 4096167A GB 1199632 A GB1199632 A GB 1199632A
Authority
GB
United Kingdom
Prior art keywords
alkyl
compositions
agents
contain
adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB40961/67A
Other languages
English (en)
Inventor
Ralph Howe
Leslie Harold Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR33270A priority Critical patent/FR1458635A/fr
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB40961/67A priority patent/GB1199632A/en
Priority to IE1011/68A priority patent/IE32287B1/xx
Priority to US754456A priority patent/US3634511A/en
Priority to CA028836A priority patent/CA921917A/en
Priority to IL30643A priority patent/IL30643A/en
Priority to DE19681793358 priority patent/DE1793358A1/de
Priority to NL6812681A priority patent/NL6812681A/xx
Priority to CS6271A priority patent/CS152306B2/cs
Priority to CH1341068A priority patent/CH518260A/de
Priority to JP43064014A priority patent/JPS5212182B1/ja
Priority to SU1270254A priority patent/SU363241A3/ru
Priority to SE12040/68A priority patent/SE353318B/xx
Priority to CH1155071A priority patent/CH553156A/xx
Priority to FR165406A priority patent/FR96559E/fr
Priority to CH1155171A priority patent/CH565137A5/xx
Priority to NO3476/68A priority patent/NO122074B/no
Priority to BE720544D priority patent/BE720544A/xx
Priority to ES357931A priority patent/ES357931A2/es
Priority to AT877668A priority patent/AT290502B/de
Priority to AT192170A priority patent/AT291969B/de
Priority to AT192270A priority patent/AT289765B/de
Priority to FR167977A priority patent/FR96560E/fr
Priority to FR327D priority patent/FR327F/fr
Publication of GB1199632A publication Critical patent/GB1199632A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB40961/67A 1964-09-30 1967-09-07 Alkanolamine Derivatives Expired GB1199632A (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR33270A FR1458635A (fr) 1964-09-30 1965-09-30 Procédé de fabrication de nouvelles alcanolamines et de leurs dérivés
GB40961/67A GB1199632A (en) 1967-09-07 1967-09-07 Alkanolamine Derivatives
IE1011/68A IE32287B1 (en) 1967-09-07 1968-08-19 Alkanolamine derivatives
US754456A US3634511A (en) 1967-09-07 1968-08-21 1-(4-acylamino-2-alkylphenoxy)-3-amino-2-propanol derivatives
CA028836A CA921917A (en) 1967-09-07 1968-08-29 Alkanolamine derivatives
IL30643A IL30643A (en) 1967-09-07 1968-08-29 1-(p-acylaminophenoxy)-3-amino-2-propanol derivatives,processes for their manufacture and pharmaceutical compositions containing them
DE19681793358 DE1793358A1 (de) 1967-09-07 1968-09-05 Alkanolaminderivate und Verfahren zu deren Herstellung
NL6812681A NL6812681A (enExample) 1967-09-07 1968-09-05
SU1270254A SU363241A3 (enExample) 1967-09-07 1968-09-06
BE720544D BE720544A (enExample) 1967-09-07 1968-09-06
JP43064014A JPS5212182B1 (enExample) 1967-09-07 1968-09-06
CS6271A CS152306B2 (enExample) 1967-09-07 1968-09-06
SE12040/68A SE353318B (enExample) 1967-09-07 1968-09-06
CH1155071A CH553156A (de) 1967-09-07 1968-09-06 Verfahren zur herstellung von alkanolaminderivaten.
FR165406A FR96559E (fr) 1964-09-30 1968-09-06 Procédé de fabrication de nouvelles alcanolamines et de leurs dérivés.
CH1155171A CH565137A5 (enExample) 1967-09-07 1968-09-06
NO3476/68A NO122074B (enExample) 1967-09-07 1968-09-06
CH1341068A CH518260A (de) 1964-09-30 1968-09-06 Verfahren zur Herstellung von Alkanolaminderivaten
ES357931A ES357931A2 (es) 1967-09-07 1968-09-07 Procedimiento para la fabricacion de derivados de alcanola-mina.
AT877668A AT290502B (de) 1967-09-07 1968-09-09 Verfahren zur Herstellung von neuen 1-(4'-Acylaminophenoxy)-2-hydroxy-3-aminopropanen sowie von deren Säureadditionssalzen
AT192170A AT291969B (de) 1967-09-07 1968-09-09 Verfahren zur Herstellung von neuen 1-(4'-Acylaminophenoxy)-2-hydroxy-3-aminopropanen sowie von deren Säureadditionssalzen
AT192270A AT289765B (de) 1967-09-07 1968-09-09 Verfahren zur Herstellung von neuen 1-(4'-Acylamino)-2-hydroxy-3-aminopropanen sowie von deren Säureadditionssalzen
FR167977A FR96560E (fr) 1964-09-30 1968-09-27 Procédé de fabrication de nouvelles alcanolamines et leurs dérivés.
FR327D FR327F (enExample) 1967-09-07 1968-12-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40961/67A GB1199632A (en) 1967-09-07 1967-09-07 Alkanolamine Derivatives

Publications (1)

Publication Number Publication Date
GB1199632A true GB1199632A (en) 1970-07-22

Family

ID=10417463

Family Applications (1)

Application Number Title Priority Date Filing Date
GB40961/67A Expired GB1199632A (en) 1964-09-30 1967-09-07 Alkanolamine Derivatives

Country Status (17)

Country Link
US (1) US3634511A (enExample)
JP (1) JPS5212182B1 (enExample)
AT (3) AT289765B (enExample)
BE (1) BE720544A (enExample)
CA (1) CA921917A (enExample)
CH (2) CH553156A (enExample)
CS (1) CS152306B2 (enExample)
DE (1) DE1793358A1 (enExample)
ES (1) ES357931A2 (enExample)
FR (1) FR327F (enExample)
GB (1) GB1199632A (enExample)
IE (1) IE32287B1 (enExample)
IL (1) IL30643A (enExample)
NL (1) NL6812681A (enExample)
NO (1) NO122074B (enExample)
SE (1) SE353318B (enExample)
SU (1) SU363241A3 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911836A (enExample) * 1972-05-15 1974-02-01
EP0100051A1 (en) * 1982-07-20 1984-02-08 A. Menarini S.a.S. New derivatives of 1-alkylamine-(4(p-alkyloxy-benzamide)phenoxy)-2-propanol, having beta-sympatholytic activity, their salts, and production processes thereof

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146558A (en) * 1966-05-23 1979-03-27 Sterling Drug Inc. Azo dyestuff intermediate nitro- or aminobenzenes ring-substituted by a quaternized amine alkyl or amino-alkoxy group
CA957364A (en) * 1968-11-18 1974-11-05 Pfizer Corporation Preparation of polar-substituted phenyl propanolamines
US4059622A (en) * 1970-05-27 1977-11-22 Imperial Chemical Industries Limited Alkanolamine derivatives
US3959486A (en) * 1970-05-27 1976-05-25 Imperial Chemical Industries Limited Method for producing β-adrenergic blockage with alkanolamine derivatives
US4206144A (en) * 1971-11-22 1980-06-03 Sterling Drug Inc. N,N-Dialkyl-N-aminoalkyl-N-(amino or nitro)phenylalkyl- and N-methyl-N-[3-(amino or nitro)phenoxy-2-hydroxy-1-propyl]-N,N-bis(3-aminopropyl)quaternary ammonium salts
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3864398A (en) * 1972-05-01 1975-02-04 Teikoku Hormone Mfg Co Ltd Process for the preparation of acylamino alkanol derivatives
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FI832377A0 (fi) * 1983-06-29 1983-06-29 Star Oy Ab Nytt foerfarande foer framstaellning av (r)-, (s)-eller (r,s)-1-(4'-alkylamido-2'-acetyl) fenoxi-3-alkylamino-2-propanoler
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911836A (enExample) * 1972-05-15 1974-02-01
EP0100051A1 (en) * 1982-07-20 1984-02-08 A. Menarini S.a.S. New derivatives of 1-alkylamine-(4(p-alkyloxy-benzamide)phenoxy)-2-propanol, having beta-sympatholytic activity, their salts, and production processes thereof

Also Published As

Publication number Publication date
DE1793358A1 (de) 1972-11-09
AT291969B (de) 1971-08-10
FR327F (enExample) 1970-09-21
IE32287L (en) 1969-03-07
CH565137A5 (enExample) 1975-08-15
US3634511A (en) 1972-01-11
IE32287B1 (en) 1973-06-13
JPS5212182B1 (enExample) 1977-04-05
AT290502B (de) 1971-06-11
IL30643A (en) 1973-01-30
BE720544A (enExample) 1969-03-06
NL6812681A (enExample) 1969-03-11
CH553156A (de) 1974-08-30
CS152306B2 (enExample) 1973-12-19
SU363241A3 (enExample) 1972-12-30
IL30643A0 (en) 1968-10-24
SE353318B (enExample) 1973-01-29
CA921917A (en) 1973-02-27
NO122074B (enExample) 1971-05-18
ES357931A2 (es) 1970-04-01
AT289765B (de) 1971-05-10

Similar Documents

Publication Publication Date Title
IE32739L (en) Alkanolamines
GB1199632A (en) Alkanolamine Derivatives
GB1455116A (en) Pharmaceutical compositions
IE39306B1 (en) Ethanolamine derivatives
GB1285038A (en) Alkanolamine derivatives
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
GB1269775A (en) Alkanolamine derivatives
GB1140860A (en) Isopropanolamine derivatives, their preparation, and pharmaceutical compositions containing them
FR2367750A1 (fr) Acid
GB1290881A (enExample)
IE36331L (en) Phenoxyalkanolamine derivatives
GB1415505A (en) Alkanolamine derivatives
IE33632L (en) Alkanolamine derivatives
GB1392610A (en) Alkanolamine derivatives
GB1312555A (en) Alkanolamine derivatives
GB1396322A (en) Alkanolamine derivatives
GB1393675A (en) Alkanolamine derivatives
GB1270723A (en) Alkanolamine derivatives
GB1414781A (en) Alkanolamine derivatives
AR240861A2 (es) Composicion fungicida.
GB1395156A (en) Aldehyde derivatives
GB1312055A (en) Alkanolamine derivatives
CA2011117A1 (en) Pradimicin amide derivatives
GB1187546A (en) Propanolamine derivatives
FR2353288A1 (fr) Composition pharmaceutique hydrosoluble a base d'un compose amine comme produit actif

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee